Form 4: agilon health Director Diana McKenzie Receives RSU Grant

Director Diana McKenzie was granted 2,133 restricted stock units as part of her compensation, following a recent 1-for-25 reverse stock split.

Summary

• Diana McKenzie, a member of the Board of Directors, was granted 2,133 restricted stock units (RSUs) on June 2, 2026.
• The RSUs are scheduled to vest in full on June 2, 2027, provided the director remains in service.
• Following this transaction, McKenzie's total beneficial ownership is 7,633 shares of common stock.
• The share counts reflect a 1-for-25 reverse stock split that became effective on March 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing. While director alignment is positive, the context of a recent 1-for-25 reverse split remains a shadow over the company's historical performance.

Positives

• Equity-based compensation aligns the interests of the director with those of the shareholders.
• The director continues to maintain a stake in the company, indicating ongoing commitment to the board.

Negatives

• The 1-for-25 reverse stock split effective March 30, 2026, suggests the company previously faced a significantly low share price, often a sign of historical financial or market distress.

Risks

• The vesting of the 2,133 RSUs is contingent upon the director's continued service through June 2027.
• Historical volatility necessitated a massive 1-for-25 reverse split to maintain listing or adjust share structure.

Future Outlook

The director's equity will vest in full in mid-2027, assuming continued board service, which ensures management stability at the board level for the coming year.

Management Comments

• The amount of securities beneficially owned reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

Industry Context

StockSavvy.ai notes that agilon health's use of RSUs for director compensation is standard within the healthcare sector to incentivize long-term oversight, though the recent heavy reverse split distinguishes it from more stable peers in the S&P 500 healthcare index.

Comparison to Industry Standards

• The RSU grant is a routine governance practice similar to those at Oak Street Health or CareMax.
• The 1-for-25 reverse split is significantly more aggressive than typical share consolidations seen in the broader healthcare services industry, which usually range from 1-for-5 to 1-for-10.

Corporate Governance

Related Party Transactions

• Grant of equity to a director is a standard related-party transaction for compensation purposes.

Stakeholder Impact

• Shareholders: Director interests are aligned with stock performance.
• Board of Directors: Diana McKenzie increases her vested interest in the company's long-term success.

Next Steps

• Vesting of 2,133 RSUs on June 2, 2027.

Key Dates

Recommendation

A routine Form 4 filing for a director grant does not provide sufficient new financial data to change a rating, though the recent reverse split suggests caution is warranted regarding the company's underlying momentum.

Keywords

agilon health, AGL, Insider Trading, Restricted Stock Units, Director Compensation, Reverse Stock Split, Healthcare Services, SEC Form 4